| Accession Number | 0001193125-26-201906 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 29, 2026 | Exercise/Conversion | 3,733 | $2.59 | $9,668.47 | 69,816 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 29, 2026 | Sale | 3,733 | $30.06 | $112,232.27 | 62,350 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 15,000 | $2.59 | $38,850.00 | 81,083 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 30, 2026 | Sale | 15,000 | $30.24 | $453,627.00 | 66,083 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 29, 2026 | Exercise/Conversion | 3,733 | $0.00 | $0.00 | 234,474 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 30, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 219,474 | Direct | โ | View Details |